RxDoctor Payments Data

Alfredo Pardo, APRN

Family · Palmetto Bay, FLNPI 1043911191

Payments from drug & device makers

$532in general payments, 2019–2025

Across 28 payments — averaging $19.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$134
  • Viiv Healthcare Company$89
  • Exact Sciences$64
  • Lilly USA, LLC$62
  • Novo Nordisk$49
  • Idorsia Pharmaceuticals US Inc$37
  • plus $99 from 5 others

What the payments were for

  • Food & beverage$532100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$532 in reported general payments places this provider in the 55th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$3,042
Medicare patients
15
Services billed
47

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide38$39,461
CreonLipase/Protease/Amylase11$9,204
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog12$2,164
BreynaBudesonide/Formoterol Fumarate11$1,677
Esomeprazole Magnesium11$913
Gabapentin49$847
Rosuvastatin Calcium54$678
Levocetirizine Dihydrochloride17$648
Vitamin D2Ergocalciferol (Vitamin D2)52$570
Famotidine37$541
Megestrol Acetate14$482
Levothyroxine Sodium44$359
Metoprolol Succinate39$325
Montelukast Sodium38$319
Pantoprazole Sodium15$303

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$62$39,46138 claims
AbbVieCreon$25$9,20411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 14,618 family providers in Florida.

Other family in Palmetto Bay

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →